Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Genetron Holdings Limited

Genetron Holdings Limited (GTH) Stock Overview

Explore Genetron Holdings Limited’s financial performance, market position, analyst ratings, and future outlook.

GTH●NASDAQ
HealthcareMedical - Diagnostics & Research
$4.03
$0.005(0.12%)
U.S. Market opens in 13h 59m

Genetron Holdings Limited (GTH)

Meyka AI Score

Z

Key Financials

Market Cap127.3M
P/E Ratio-0.95
EPS (TTM)$-3.62
ROE-1.01%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

GTH Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Genetron Holdings Limited (NASDAQ: GTH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Genetron Holdings Limited's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of GTH on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Genetron Holdings Limited's NASDAQ-traded stock include a P/E ratio of -0.95 and a market capitalization of 127.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of GTH on the NASDAQ.

Price Performance (NASDAQ: GTH)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.12%
3-Month Change
6.20%
6-Month Change
15.33%
Year-to-Date (YTD) Change
9.08%
1-Year Change
42.73%
3-Year Change
-93.92%
5-Year Change
-91.61%
All-Time (Max) Change
-91.61%

Contact Information

https://www.genetronhealth.com
86 10 5090 7500
Building 11, Beijing, NaN, 102206

Company Facts

9,930 Employees
IPO DateJun 15, 2020
CountryCN

Frequently Asked Questions